2m 2m 2m 2m 2m 2m 2m
Lexicon Pharma (LXRX)
NASDAQ
$1.52-$0.04 (-2.56%)
Price as of Oct 22, 2026 7:30 PM EDT- $694.1MMarket Cap
- 12.23%1-Year Change
- BiotechnologyIndustry
Lexicon Pharma (LXRX)
$1.52-$0.04 (-2.56%)
LXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.56 | ||
Change | -$0.02 (-1.27%) | ||
Open | $1.59 | ||
High | $1.62 | ||
Low | $1.54 | ||
Previous Close | $1.58 | ||
Volume | 1,396,132 | ||
30-Day Average Volume | 2,782,472 | ||
1-Week Change | -2.50% | ||
1-Month Change | -23.53% | ||
1-Year Change | 12.23% | ||
3-Year Change | 38.05% | ||
5-Year Change | -69.77% | ||
Fundamentals | |||
Shares Outstanding | 445.0M | ||
Total Assets | $250.1M | ||
Market Cap | $694.1M | ||
Enterprise Value | $704.6M | ||
Period: QTR TTM FY | |||
Revenue | $692,000.00 | ||
Net Income | -$31.8M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$31.8M | ||
EBITDA | -$31.7M | ||
Net Working Capital | $181.9M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | 1,018 | ||
P/B | 4 | ||
P/E | -22 | ||
PEG | N/A | ||
Price/Free Cash Flow | -76 | ||
Price/Operating Cash Flow | -76 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/21/2015 | ||
Earnings & Revenue